Senores Pharmaceuticals Ltd has concluded its Initial Public Offering (IPO) with an overwhelming subscription of 93.69 times across all categories, including Non-Institutional Investors (NIIs), Qualified Institutional Buyers (QIBs), Retail Individual Investors (RIIs), and the Employee portion. The IPO, which raised Rs 8.5 crore, attracted bids for a staggering 79,95,96,646 shares against the 85,34,681 shares on offer.
The highest demand came from Non-Institutional Investors and Qualified Institutional Buyers, followed by Retail Investors and Employees.
Ahead of the public offering, Senores Pharmaceuticals secured Rs 261 crore from anchor investors, ensuring strong backing for the IPO.
Category-Wise Subscription Breakdown
Here is the subscription performance for the Senores Pharma IPO across different investor categories:
- Non-Institutional Investors: Subscribed 96.30 times with bids for 22,33,98,732 shares against 23,19,879 shares allocated to them.
- Qualified Institutional Buyers (QIBs): Subscribed 94.66 times with bids for 43,47,78,102 shares against 45,93,216 shares reserved for them.
- Retail Investors: Subscribed 90.46 times with bids for 13,99,04,334 shares against 15,46,586 shares allocated to them.
- Employees: The employee portion was subscribed 20.21 times with bids for 15,15,478 shares against 75,000 shares.
Senores Pharma IPO Allotment and Listing Details
For those eagerly awaiting allotment and listing details, the allotment date for the Senores Pharma IPO is December 26, 2024. Here’s how you can check your IPO allotment status:
- Visit the official registrar website of Link Intime India Pvt Ltd: linkintime.co.in/initial_offer/public-issues.html.
- Select “Senores Pharmaceuticals Ltd” from the list of IPOs.
- Enter your PAN card number, application number, demat account number, or account details along with the IFSC code.
- Click “Submit” to view the status of your application.
The stock of Senores Pharmaceuticals will be listed on both the NSE and BSE exchanges on December 30, 2024.
About Senores Pharmaceuticals Ltd
Senores Pharmaceuticals Ltd is a global pharmaceutical company specializing in the development and manufacturing of complex and underpenetrated products across various therapeutic areas and dosage forms. The company also has a strong presence in the critical care injectables segment, reinforcing its commitment to providing high-quality healthcare solutions globally.
